Keywords: valeant, sales, rise, usa, pharmaceuticals, reported, net

Valeant sales rise 22%

Article | 16 May 2005

Print This

The USA's Valeant Pharmaceuticals has reported a net loss of $139.3 million, or $1.57 per share, for the first quarter of 2005 versus $13.6 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in